Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#3069 Functioning Pancreatic Neuroendocrine Tumors (F-pNETs): The Experience of a Tertiary Care Center of Pancreatic Surgery

Introduction: Surgery represents the optimal treatment of F-pNETs, especially if performed in high volume centers of pancreatic surgery.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Nessi C, Lenzi S, Landoni L, Bianchi B, Elio G,

Keywords: Functioning pancreatic neuroendocrine tumors, pancreatic surgery,

#2931 One-Stage Middle-Preserving Pancreatectomy: Indications and Outcomes

Introduction: Parenchyma-sparing surgical techniques are used in pancreatic surgery to preserve organ function. Middle-preserving pancreatectomy (MPP) may be an alternative to total pancreatectomy (TP) in benign/borderline disease that does not affect pancreatic body.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Milanetto A, David A, Fassan M, Pasquali C,

Keywords: one-stage middle preserving pancreatectomy, parenchyma-sparing pancreatic surgery,

#2911 Pancreatic Neuroendocrine Neoplasms and GastroIntestinal Stromal Tumours: A Single-Institution Experience of a Rare Association and Review of the Literature

Introduction: Pancreatic neuroendocrine neoplasms (pNENs) and gastrointestinal stromal tumours (GISTs) are both rare neoplasms, and they have an estimated incidence of about 1/100,000 per year and about 1-1.5/100,000 per year, respectively.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Milanetto A, Pacciani S, Da Broi M, Gais Zürcher A, Fassan M,

Keywords: pancreatic neuroendocrine neoplasm, gastrointestinal stromal tumour, pancreatic surgery,

#2243 Somatostatin Analogs (SSAs) as Effective Treatment of Resectable, non Metastatic, non Functioning Pancreatic Neuroendocrine Tumors (NF-pNETs) in Patients Unfit for Surgery. A Case Series.

Introduction: SSAs are used to treat symptomatic functioning pNETs and to prolong progression free survival in metastatic, G1/G2, somatostatin receptor-positive pNETs. Pancreatic surgery is burdened with important morbidity and mortality, especially in patients with increased anaesthesiological risk.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Nessi C, Paiella S, Miotto M, Viviani E, Zingaretti C,

Keywords: somatostatin analogs, resectable pnets,

#2241 Patterns of Recurrence after Resection for Pancreatic Neuroendocrine Tumors: Who, When, and How?

Introduction: Pancreatic Neuroendocrine Tumors (pNETs) represent an increasing indication for pancreatic resection, but there are only few data about their possible recurrence after surgery.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Masini G, Andrianello S, Marchegiani G, Nessi C, Capelli P,

Keywords: neuroendocrine, pancreas, surgery, recurrence, follow-up,